| Epigenetic modulation of antitumor immunity for improved cancer immunotherapy E Dai, Z Zhu, S Wahed, Z Qu, WJ Storkus, ZS Guo Molecular cancer 20, 1-27, 2021 | 134 | 2021 |
| Evaluation of the seventh edition of American Joint Committee on Cancer TNM staging system for gastric cancer: results from a Chinese monoinstitutional study Z Sun, Z Wang, Z Zhu, Y Xu, Y Xu, B Huang, G Zhu, H Xu Annals of surgical oncology 19, 1918-1927, 2012 | 104 | 2012 |
| Expression of legumain correlates with prognosis and metastasis in gastric carcinoma P Guo, Z Zhu, Z Sun, Z Wang, X Zheng, H Xu PloS one 8 (9), e73090, 2013 | 71 | 2013 |
| Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach G Zhu, Z Sun, Z Wang, Y Xu, B Huang, Y Xu, Z Zhu, H Xu Journal of surgical oncology 105 (8), 786-792, 2012 | 60 | 2012 |
| Prognostic significance of tumor deposits in gastric cancer patients who underwent radical surgery Z Sun, Z Wang, Y Xu, G Zhu, B Huang, Y Xu, F Liu, Z Zhu, H Xu Surgery 151 (6), 871-881, 2012 | 57 | 2012 |
| Bi-and tri-specific T cell engager-armed oncolytic viruses: next-generation cancer immunotherapy ZS Guo, MT Lotze, Z Zhu, WJ Storkus, XT Song Biomedicines 8 (7), 204, 2020 | 50 | 2020 |
| The prognostic impact of occult lymph node metastasis in node-negative gastric cancer: a systematic review and meta-analysis J Huang, Y Xu, M Li, Z Sun, Z Zhu, Y Song, Z Miao, J Wu, H Xu Annals of surgical oncology 20, 3927-3934, 2013 | 48 | 2013 |
| Flotillin2 expression correlates with HER2 levels and poor prognosis in gastric cancer Z Zhu, J Wang, Z Sun, X Sun, Z Wang, H Xu PloS one 8 (5), e62365, 2013 | 47 | 2013 |
| Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer J Huang, Y Xu, Z Sun, Z Wang, Z Zhu, Y Song, Y Luo, X Zhang, H Xu Journal of Surgical Research 192 (2), 494-502, 2014 | 42 | 2014 |
| Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways Z Zhu, AJR McGray, W Jiang, B Lu, P Kalinski, ZS Guo Molecular cancer 21 (1), 196, 2022 | 41 | 2022 |
| Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy M Feist, Z Zhu, E Dai, C Ma, Z Liu, E Giehl, R Ravindranathan, ... Cancer gene therapy 28 (1), 98-111, 2021 | 37 | 2021 |
| Prognostic value of tumor size in gastric cancer: an analysis of 2,379 patients P Guo, Y Li, Z Zhu, Z Sun, C Lu, Z Wang, H Xu Tumor Biology 34, 1027-1035, 2013 | 34 | 2013 |
| Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer Z Zhu, Z Sun, Z Wang, P Guo, X Zheng, H Xu Journal of Surgical Research 183 (1), 177-183, 2013 | 28 | 2013 |
| Clinical and pathological staging of gastric cancer: current perspectives and implications Z Zhu, Y Gong, H Xu European Journal of Surgical Oncology 46 (10), e14-e19, 2020 | 27 | 2020 |
| Benefits of surgery after neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal metastasis: A meta-analysis Y Gong, P Wang, Z Zhu, J Zhang, J Huang, T Wang, J Chen, H Xu Journal of Surgical Research 245, 234-243, 2020 | 26 | 2020 |
| Histopathology-based prognostic score is independent prognostic factor of gastric carcinoma Z Zhu, X Sun, J Wang, Z Sun, Z Wang, X Zheng, H Xu BMC cancer 14, 1-10, 2014 | 25 | 2014 |
| Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer Y Lu, P Lu, Z Zhu, H Xu, X Zhu Journal of Experimental & Clinical Cancer Research 28, 1-9, 2009 | 23 | 2009 |
| Borrmann type IV gastric cancer should be classified as pT4b disease J Huang, Z Wang, C Lu, Z Miao, Z Zhu, Y Song, H Xu, Y Xu journal of surgical research 203 (2), 258-267, 2016 | 22 | 2016 |
| Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis S Pan, P Wang, Y Xing, K Li, Z Wang, H Xu, Z Zhu Cancer Communications 39, 1-12, 2019 | 21 | 2019 |
| Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo X Dong, W Qu, S Ma, Z Zhu, C Zheng, A He, A Karlsson, K Xu, X Zheng Cancer letters 328 (1), 95-103, 2013 | 21 | 2013 |
